
About Neuromics
Neuromics is a company based in Edina (United States) founded in 2003. It operates as a B2B. Neuromics offers products and services including Human Primary Cells, Antibodies, and Fetal Bovine Serum. Neuromics operates in a competitive market with competitors including Bio Rad, Abcam, Siemens Healthineers, Merck and Quanterix, among others.
- Headquarter Edina, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website neuromics.com
- Social LinkedIn X Facebook
Products & Services of Neuromics
Neuromics offers a comprehensive portfolio of products and services, including Human Primary Cells, Antibodies, and Fetal Bovine Serum.
Cells for neuroscience and cancer research applications.
Antibodies for protein detection in lab experiments.
Serum supporting cell growth in scientific studies.
People of Neuromics
1 people are tracked at Neuromics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Pete Shuster | CEO and Owner | Leadership |
Complete people profiles for Neuromics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Neuromics
Neuromics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Abcam, Siemens Healthineers, Merck and Quanterix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | |
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| siemens-healthineers.com | 1847 | Erlangen, Germany | – | 66,000 | AI-based medical diagnostics are developed for healthcare applications. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. |
Detailed competitors of Neuromics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Neuromics
The website of Neuromics (neuromics.com) receives about 25.3K visits a month.
- Monthly visits25.3K
▲ 36.7% vs previous month
Websites whose visitors overlap most with Neuromics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genmab.com | 100% | 124K | #263,421 | View details | |
| iba-lifesciences.com | 100% | 15.2K | #1,289,679 | View details | |
| haemtech.com | 100% | – | – | View details | |
| i-cyt.com | 87% | – | – | View details | |
| corning.com | 86% | 606.5K | #95,499 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 11 similar websites and full traffic analytics for Neuromics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Neuromics
10 companies that operate in the same segment as Neuromics (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 300 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Neuromics
Neuromics was founded in 2003.
Neuromics is headquartered in Edina, United States. It is registered at Edina, Minnesota, United States.
Neuromics provides biotechnology reagents including human primary cells, iPSC-derived cells, antibodies, and fetal bovine serum. Based in Edina, Minnesota, USA, they support researchers in neuroscience, cancer, and life sciences by offering tools for cell culturing, assays, and drug studies. Their products are used in labs for experiments involving cell growth and protein detection.
Neuromics's top competitors include Abcam, Biocare Medical and Sino Biological.
Neuromics offers Human Primary Cells, Antibodies, and Fetal Bovine Serum.